Novartis sets aside $700 million to settle bribery charges in the U.S.

Novartis sets aside $700 million to settle bribery charges in the U.S.

STAT Plus: Novartis sets aside $700 million to settle long-running bribery allegations in the U.S.

By ED SILVERMAN

RUBY WALLAU FOR STAT

A deal would give Novartis a much-needed opportunity to dispense with a string of well-publicized cases involving bribes paid in the U.S. and elsewhere.

READ MORE